Botox therapy for refractory chronic migraine

被引：20
|
作者：
Conway, S [1 ]
Delplanche, C [1 ]
Crowder, J [1 ]
Rothrock, J [1 ]
机构：
[1] Univ S Alabama, Headache Ctr, Mobile, AL 36693 USA
来源：
HEADACHE | 2005年 / 45卷 / 04期
关键词：
chronic migraine; botulinum toxin type A; BOTOX;
D O I：
10.1111/j.1526-4610.2005.05073a.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Chronic migraine is unfortunately both common and often resistant to treatment even with prophylactic medications known to be effective in populations with episodic migraine. We undertook an open-label study to evaluate the safety and utility of botulinum toxin type A injection therapy for patients with chronic migraine who previously had failed to respond to at least three prophylactic medications.
引用
收藏
页码：355 / 357
页数：3
相关论文
共 50 条
  • [41] Do Botox and Xeomin Differ with Respect to Tolerability and Effectiveness in Treatment of Chronic Migraine?
    Lucchese, S.
    HEADACHE, 2018, 58 : 101 - 101
  • [42] OnabotulinumtoxinA (BOTOX®)A Review of its Use in the Prophylaxis of Headaches in Adults with Chronic Migraine
    James E. Frampton
    Drugs, 2012, 72 : 825 - 845
  • [43] An open/pilot trial of cognitive behavioral therapy in Turkish patients with refractory chronic migraine
    Ozge Sahmelikoglu Onur
    Devrimsel Harika Ertem
    Cagatay Karsidag
    Derya Uluduz
    Aynur Ozge
    Aksel Sıva
    Meltem Guru
    Cognitive Neurodynamics, 2019, 13 : 183 - 189
  • [44] An open/pilot trial of cognitive behavioral therapy in Turkish patients with refractory chronic migraine
    Onur, Ozge Sahmelikoglu
    Ertem, Devrimsel Harika
    Karsidag, Cagatay
    Uluduz, Derya
    Ozge, Aynur
    Siva, Aksel
    Guru, Meltem
    COGNITIVE NEURODYNAMICS, 2019, 13 (02) : 183 - 189
  • [45] Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
    Hansson-Hedblom, Amanda
    Axelsson, Isabelle
    Jacobson, Lena
    Tedroff, Joakim
    Borgstrom, Fredrik
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [46] Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
    Amanda Hansson-Hedblom
    Isabelle Axelsson
    Lena Jacobson
    Joakim Tedroff
    Fredrik Borgström
    The Journal of Headache and Pain, 2020, 21
  • [47] Naratriptan in the preventive treatment of refractory chronic migraine
    Rapoport, A
    Bigal, M
    Sheftell, F
    Volcy, M
    Feleppa, M
    Tepper, S
    CEPHALALGIA, 2003, 23 (07) : 751 - 751
  • [48] Combined Interventional Treatment of Refractory Chronic Migraine
    Alexey G. Voloshin
    Irina V. Moiseeva
    SN Comprehensive Clinical Medicine, 2021, 3 (6) : 1320 - 1326
  • [49] Occipital nerve stimulation for refractory chronic migraine
    Bermejo, Pedro E.
    Torres, Cristina V.
    Sola, Rafael G.
    REVISTA DE NEUROLOGIA, 2015, 60 (11) : 509 - 516
  • [50] Botulinum toxin type a in refractory chronic migraine
    Menezes, Carla
    Rodrigues, Bernardo
    Magalhaes, Elza
    Melo, Ailton
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3A) : 596 - 598
12345